Skip to main content
Top
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | Fatigue | Research

Nationwide epidemiological characteristics of chronic fatigue syndrome in South Korea

Authors: Eun-Jin Lim, Jin-Seok Lee, Eun-Jung Lee, Seok-Ju Jeong, Ho-Young Park, Yo-Chan Ahn, Chang-Gue Son

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

Background

Chronic fatigue syndrome (CFS) is a long-term disabling illness accompanied by medically unexplained fatigue. This study aimed to explore the epidemiological characteristics of CFS in South Korea.

Methods

Using the nationwide medical records provided by the Korean Health Insurance Review & Assessment Service (HIRA), we analyzed the entire dataset for CFS patients diagnosed by physicians in South Korea from January 2010 to December 2020.

Results

The annual mean incidence of CFS was estimated to be 44.71 ± 6.10 cases per 100,000 individuals [95% CI: 40.57, 48.76], and the prevalence rate was 57.70 ± 12.20 cases per 100,000 individuals [95% CI: 49.40, 65.79]. These two rates increased by 1.53- and 1.94-fold from 2010 to 2020, respectively, and showed an increasing trend with aging and an approximately 1.5-fold female predominance.

Conclusions

This study is the first to report the nationwide epidemiological features of CFS, which reflects the clinical reality of CFS diagnosis and care in South Korea. This study will be a valuable reference for studies of CFS in the future.
Literature
1.
go back to reference Yoo EH, Choi ES, Cho SH, Do JH, Lee SJ, Kim JH. Comparison of fatigue severity and quality of life between unexplained fatigue patients and explained fatigue patients. Korean J Fam Med. 2018;39:180–4.CrossRef Yoo EH, Choi ES, Cho SH, Do JH, Lee SJ, Kim JH. Comparison of fatigue severity and quality of life between unexplained fatigue patients and explained fatigue patients. Korean J Fam Med. 2018;39:180–4.CrossRef
2.
go back to reference Pendergrast T, Brown A, Sunnquist M, Jantke R, Newton JL, Strand EB, Jason LA. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016;12:292–307.CrossRef Pendergrast T, Brown A, Sunnquist M, Jantke R, Newton JL, Strand EB, Jason LA. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016;12:292–307.CrossRef
3.
go back to reference Kapur N, Webb R. Suicide risk in people with chronic fatigue syndrome. Lancet. 2016;387:1596–7.CrossRef Kapur N, Webb R. Suicide risk in people with chronic fatigue syndrome. Lancet. 2016;387:1596–7.CrossRef
5.
go back to reference Wong WS, Fielding R. Prevalence of chronic fatigue among Chinese adults in Hong Kong: a population-based study. J Affect Disord. 2010;127:248–56.CrossRef Wong WS, Fielding R. Prevalence of chronic fatigue among Chinese adults in Hong Kong: a population-based study. J Affect Disord. 2010;127:248–56.CrossRef
6.
go back to reference Estévez-López F, Mudie K, Wang-Steverding X, Bakken IJ, Ivanovs A, Castro-Marrero J, Nacul L, Alegre J, Zalewski P, Słomko J, Strand EB, Pheby D, Shikova E, Lorusso L, Capelli E, Sekulic S, Scheibenbogen C, Sepúlveda N, Murovska M, Lacerda E. Systematic review of the epidemiological burden of myalgic encephalomyelitis/chronic fatigue syndrome across Europe: current evidence and EUROMENE research recommendations for epidemiology. J Clin Med. 2020;9:1557.CrossRef Estévez-López F, Mudie K, Wang-Steverding X, Bakken IJ, Ivanovs A, Castro-Marrero J, Nacul L, Alegre J, Zalewski P, Słomko J, Strand EB, Pheby D, Shikova E, Lorusso L, Capelli E, Sekulic S, Scheibenbogen C, Sepúlveda N, Murovska M, Lacerda E. Systematic review of the epidemiological burden of myalgic encephalomyelitis/chronic fatigue syndrome across Europe: current evidence and EUROMENE research recommendations for epidemiology. J Clin Med. 2020;9:1557.CrossRef
7.
go back to reference Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18:100.CrossRef Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18:100.CrossRef
8.
go back to reference Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Håberg SE, Magnus P. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012. BMC Med. 2014;12:167.PubMedPubMedCentral Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Håberg SE, Magnus P. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012. BMC Med. 2014;12:167.PubMedPubMedCentral
9.
go back to reference Piccini P, Montagnani C, de Martino M. Gender disparity in pediatrics: a review of the current literature. Ital J Pediatr. 2018;44:1.CrossRef Piccini P, Montagnani C, de Martino M. Gender disparity in pediatrics: a review of the current literature. Ital J Pediatr. 2018;44:1.CrossRef
11.
go back to reference Lim EJ, Son CG. Prevalence of chronic fatigue syndrome (CFS) in Korea and Japan: a meta-analysis. J Clin Med. 2021;10:3204.CrossRef Lim EJ, Son CG. Prevalence of chronic fatigue syndrome (CFS) in Korea and Japan: a meta-analysis. J Clin Med. 2021;10:3204.CrossRef
12.
go back to reference Ranjith G. Epidemiology of chronic fatigue syndrome. Occup Med (Lond). 2005;55:13–9.CrossRef Ranjith G. Epidemiology of chronic fatigue syndrome. Occup Med (Lond). 2005;55:13–9.CrossRef
13.
go back to reference Bazelmans E, Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van Weel C, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome and primary fibromyalgia syndrome as recognized by GPs. Fam Pract. 1999;16:602–4.CrossRef Bazelmans E, Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van Weel C, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome and primary fibromyalgia syndrome as recognized by GPs. Fam Pract. 1999;16:602–4.CrossRef
14.
go back to reference Van Hoof E. The doctor-patient relationship in chronic fatigue syndrome: survey of patient perspectives. Qual Prim Care. 2009;17:263–70.PubMed Van Hoof E. The doctor-patient relationship in chronic fatigue syndrome: survey of patient perspectives. Qual Prim Care. 2009;17:263–70.PubMed
15.
go back to reference Cullinan J, Pheby DFH, Araja D, Berkis U, Brenna E, de Korwin JD, Gitto L, Hughes DA, Hunter RM, Trepel D, Wang-Steverding X. Perceptions of European ME/CFS experts concerning knowledge and understanding of ME/CFS among primary care physicians in Europe: a report from the European ME/CFS research network (EUROMENE). Medicina (Kaunas). 2021;57:208.CrossRef Cullinan J, Pheby DFH, Araja D, Berkis U, Brenna E, de Korwin JD, Gitto L, Hughes DA, Hunter RM, Trepel D, Wang-Steverding X. Perceptions of European ME/CFS experts concerning knowledge and understanding of ME/CFS among primary care physicians in Europe: a report from the European ME/CFS research network (EUROMENE). Medicina (Kaunas). 2021;57:208.CrossRef
17.
go back to reference Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, Randall B, Stewart JA, Abbey S, Jones JF, Gantz N, Minden S, Reeves WC. Prevalence and incidence of chronic fatigue syndrome in Wichita. Kansas Arch Intern Med. 2003;163:1530–6.CrossRef Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, Randall B, Stewart JA, Abbey S, Jones JF, Gantz N, Minden S, Reeves WC. Prevalence and incidence of chronic fatigue syndrome in Wichita. Kansas Arch Intern Med. 2003;163:1530–6.CrossRef
18.
go back to reference Vincent A, Brimmer DJ, Whipple MO, Jones JF, Boneva R, Lahr BD, Maloney E, St Sauver JL, Reeves WC. Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted county, Minnesota, as estimated using the Rochester epidemiology project. Mayo Clin Proc. 2012;87:1145–52.CrossRef Vincent A, Brimmer DJ, Whipple MO, Jones JF, Boneva R, Lahr BD, Maloney E, St Sauver JL, Reeves WC. Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted county, Minnesota, as estimated using the Rochester epidemiology project. Mayo Clin Proc. 2012;87:1145–52.CrossRef
19.
go back to reference Lim EJ, Son CG. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2020;18:289.CrossRef Lim EJ, Son CG. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2020;18:289.CrossRef
20.
go back to reference Collin SM, Bakken IJ, Nazareth I, Crawley E, White PD. Trends in the incidence of chronic fatigue syndrome and fibromyalgia in the UK, 2001–2013: a clinical practice research datalink study. J R Soc Med. 2017;110:231–44.CrossRef Collin SM, Bakken IJ, Nazareth I, Crawley E, White PD. Trends in the incidence of chronic fatigue syndrome and fibromyalgia in the UK, 2001–2013: a clinical practice research datalink study. J R Soc Med. 2017;110:231–44.CrossRef
21.
go back to reference Bayliss K, Goodall M, Chisholm A, Fordham B, Chew-Graham C, Riste L, Fisher L, Lovell K, Peters S, Wearden A. Overcoming the barriers to the diagnosis and management of chronic fatigue syndrome/ME in primary care: a meta synthesis of qualitative studies. BMC Fam Pract. 2014;15:44.CrossRef Bayliss K, Goodall M, Chisholm A, Fordham B, Chew-Graham C, Riste L, Fisher L, Lovell K, Peters S, Wearden A. Overcoming the barriers to the diagnosis and management of chronic fatigue syndrome/ME in primary care: a meta synthesis of qualitative studies. BMC Fam Pract. 2014;15:44.CrossRef
22.
go back to reference Horton-Salway M. Bio-psycho-social reasoning in GPs’ case narratives: the discursive construction of ME patients’ identities. Health. 2002;6:401–21.CrossRef Horton-Salway M. Bio-psycho-social reasoning in GPs’ case narratives: the discursive construction of ME patients’ identities. Health. 2002;6:401–21.CrossRef
23.
go back to reference Speight N. Myalgic encephalomyelitis/chronic fatigue syndrome: review of history, clinical features, and controversies. Saudi J Med Med Sci. 2013;1:11–3.CrossRef Speight N. Myalgic encephalomyelitis/chronic fatigue syndrome: review of history, clinical features, and controversies. Saudi J Med Med Sci. 2013;1:11–3.CrossRef
24.
go back to reference Jung JH, Park HK. Experiences of illness and socialization of suffering in patients with chronic fatigue syndrome. Health Soc Sci. 2016;8:5–38.CrossRef Jung JH, Park HK. Experiences of illness and socialization of suffering in patients with chronic fatigue syndrome. Health Soc Sci. 2016;8:5–38.CrossRef
27.
go back to reference Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc. 2004;2:1–6.CrossRef Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc. 2004;2:1–6.CrossRef
28.
go back to reference Capelli E, Zola R, Lorusso L, Venturini L, Sardi F, Ricevuti G. Chronic fatigue syndrome/myalgic encephalomyelitis: an update. Int J Immunopathol Pharmacol. 2010;23:981–9.CrossRef Capelli E, Zola R, Lorusso L, Venturini L, Sardi F, Ricevuti G. Chronic fatigue syndrome/myalgic encephalomyelitis: an update. Int J Immunopathol Pharmacol. 2010;23:981–9.CrossRef
29.
go back to reference Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2019;7:12.CrossRef Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2019;7:12.CrossRef
31.
go back to reference Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, Bateman L, DeMaria A Jr, Lapp CW, Rowe PC, Proskauer C. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front Pediatr. 2018;6:412.CrossRef Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, Bateman L, DeMaria A Jr, Lapp CW, Rowe PC, Proskauer C. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front Pediatr. 2018;6:412.CrossRef
32.
go back to reference Kim SH. Prevalence of chronic widespread pain and chronic fatigue syndrome in young Korean adults. J Musculoskeletal Pain. 2008;16:149–53.CrossRef Kim SH. Prevalence of chronic widespread pain and chronic fatigue syndrome in young Korean adults. J Musculoskeletal Pain. 2008;16:149–53.CrossRef
33.
go back to reference Kim SH, Lee K, Lim HS. Prevalence of chronic widespread pain and chronic fatigue syndrome in Korean livestock raisers. J Occup Health. 2008;50:525–8.CrossRef Kim SH, Lee K, Lim HS. Prevalence of chronic widespread pain and chronic fatigue syndrome in Korean livestock raisers. J Occup Health. 2008;50:525–8.CrossRef
34.
go back to reference Ji JD, Choi SJ, Lee YH, Song GG. Incidence and clinical manifestations of chronic fatigue in Korea. Korean J Med. 1999;56:738–44. Ji JD, Choi SJ, Lee YH, Song GG. Incidence and clinical manifestations of chronic fatigue in Korea. Korean J Med. 1999;56:738–44.
35.
go back to reference Ji JD, Choi YS, Chun BC, Choi SJ, Lee YH, Song GG. The prevalence and clinical manifestations of chronic fatigue syndrome in persons who visited health management center. Korean J Med. 2000;59:529–34. Ji JD, Choi YS, Chun BC, Choi SJ, Lee YH, Song GG. The prevalence and clinical manifestations of chronic fatigue syndrome in persons who visited health management center. Korean J Med. 2000;59:529–34.
36.
go back to reference Kim CH, Shin HC, Won CW. Prevalence of chronic fatigue and chronic fatigue syndrome in Korea: community-based primary care study. J Korean Med Sci. 2005;20:529–34.CrossRef Kim CH, Shin HC, Won CW. Prevalence of chronic fatigue and chronic fatigue syndrome in Korea: community-based primary care study. J Korean Med Sci. 2005;20:529–34.CrossRef
37.
go back to reference Kim DY, Lee JS, Son CG. Systematic review of primary outcome measurements for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in randomized controlled trials. J Clin Med. 2020;9:3463.CrossRef Kim DY, Lee JS, Son CG. Systematic review of primary outcome measurements for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in randomized controlled trials. J Clin Med. 2020;9:3463.CrossRef
38.
go back to reference Solomon L, Reeves WC. Factors influencing the diagnosis of chronic fatigue syndrome. Arch Intern Med. 2004;164:2241–5.CrossRef Solomon L, Reeves WC. Factors influencing the diagnosis of chronic fatigue syndrome. Arch Intern Med. 2004;164:2241–5.CrossRef
39.
go back to reference Kim HG, Cho JH, Yoo SR, Lee JS, Han JM, Lee NH, Ahn YC, Son CG. Antifatigue effects of Panax ginseng CA Meyer: a randomised, double-blind, placebo-controlled trial. PLoS ONE. 2013;8(4):e61271.CrossRef Kim HG, Cho JH, Yoo SR, Lee JS, Han JM, Lee NH, Ahn YC, Son CG. Antifatigue effects of Panax ginseng CA Meyer: a randomised, double-blind, placebo-controlled trial. PLoS ONE. 2013;8(4):e61271.CrossRef
40.
go back to reference Castro-Marrero J, Zaragozá MC, López-Vílchez I, Galmés JL, Cordobilla B, Maurel S, Domingo JC, Alegre-Martín J. Effect of Melatonin plus zinc supplementation on fatigue perception in myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial. Antioxidants (Basel). 2021;10(7):1010.CrossRef Castro-Marrero J, Zaragozá MC, López-Vílchez I, Galmés JL, Cordobilla B, Maurel S, Domingo JC, Alegre-Martín J. Effect of Melatonin plus zinc supplementation on fatigue perception in myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial. Antioxidants (Basel). 2021;10(7):1010.CrossRef
41.
go back to reference Eftekhari A, Dizaj SM, Chodari L, Sunar S, Hasanzadeh A, Ahmadian E, Hasanzadeh M. The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities. Biomed Pharmacother. 2018;103:1018–27.CrossRef Eftekhari A, Dizaj SM, Chodari L, Sunar S, Hasanzadeh A, Ahmadian E, Hasanzadeh M. The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities. Biomed Pharmacother. 2018;103:1018–27.CrossRef
Metadata
Title
Nationwide epidemiological characteristics of chronic fatigue syndrome in South Korea
Authors
Eun-Jin Lim
Jin-Seok Lee
Eun-Jung Lee
Seok-Ju Jeong
Ho-Young Park
Yo-Chan Ahn
Chang-Gue Son
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Fatigue
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-03170-0

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.